87 related articles for article (PubMed ID: 20494380)
1. Purine metabolite levels in preovulatory human follicles may hold the key to ovarian hyperstimulation syndrome.
Iles RK; Docherty SM
Metabolism; 2010 Oct; 59(10):e10-1. PubMed ID: 20494380
[No Abstract] [Full Text] [Related]
2. [Ovarian hyperstimulation syndrome. Diagnosis and prevention are extremely important].
Nylund L; Carlström K; Gustafson O
Lakartidningen; 1993 Mar; 90(10):915-7. PubMed ID: 8459733
[No Abstract] [Full Text] [Related]
3. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
Zhu WJ; Li XM; Chen XM; Zhang L
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
[TBL] [Abstract][Full Text] [Related]
4. Pleural effusion after in-vitro fertilization: consider ovarian hyperstimulation.
Sohan K; Ramsewak SS
West Indian Med J; 2004 Sep; 53(4):265. PubMed ID: 15624248
[No Abstract] [Full Text] [Related]
5. Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization.
Delbaere A; Smits G; Vassart G; Costagliola S
Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):590-1. PubMed ID: 17082800
[No Abstract] [Full Text] [Related]
6. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
Vrtovec HM; Tomazevic T
J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
[TBL] [Abstract][Full Text] [Related]
7. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
Tozer AJ; Iles RK; Iammarrone E; Gillott CM; Al-Shawaf T; Grudzinskas JG
Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
[TBL] [Abstract][Full Text] [Related]
8. Ovarian hyperstimulation syndrome.
Avecillas JF; Falcone T; Arroliga AC
Crit Care Clin; 2004 Oct; 20(4):679-95, ix. PubMed ID: 15388196
[TBL] [Abstract][Full Text] [Related]
9. [Assisted reproduction and risks of superovulation].
Seppälä M; Tiitinen A; Teramo K; Raivio K
Duodecim; 1996; 112(4):245-7. PubMed ID: 10590636
[No Abstract] [Full Text] [Related]
10. The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.
Owj M; Tehrani-Nejad ES; Amirchaghmaghi E; Baghestani AR; Ahmadi J
Saudi Med J; 2005 Oct; 26(10):1584-7. PubMed ID: 16228060
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum müllerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization.
Nakhuda GS; Chu MC; Wang JG; Sauer MV; Lobo RA
Fertil Steril; 2006 May; 85(5):1541-3. PubMed ID: 16566934
[TBL] [Abstract][Full Text] [Related]
12. Ovarian hyperstimulation syndrome: an important complication of in vitro fertilization.
Justice HM; Counselman FL
Am J Emerg Med; 2008 Jan; 26(1):115.e3-4. PubMed ID: 18082809
[No Abstract] [Full Text] [Related]
13. Severe ovarian hyperstimulation syndrome: serum and ascitic fluid concentrations of vascular endothelial growth factor.
Agrawal R; Chimusoro K; Payne N; van der Spuy Z; Jacobs HS
Curr Opin Obstet Gynecol; 1997 Apr; 9(2):141-4. PubMed ID: 9204237
[No Abstract] [Full Text] [Related]
14. Antral follicle count as a predictor of hyperresponse in controlled ovarian hyperstimulation/intrauterine insemination in unexplained sterility.
Checa MA; Prat M; Carreras R
Fertil Steril; 2010 Aug; 94(3):1105-7. PubMed ID: 20045519
[TBL] [Abstract][Full Text] [Related]
15. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
16. Luteinization of porcine preovulatory follicles leads to systematic changes in follicular gene expression.
Agca C; Ries JE; Kolath SJ; Kim JH; Forrester LJ; Antoniou E; Whitworth KM; Mathialagan N; Springer GK; Prather RS; Lucy MC
Reproduction; 2006 Jul; 132(1):133-45. PubMed ID: 16816339
[TBL] [Abstract][Full Text] [Related]
17. Two cases of cholestasis in the first trimester of pregnancy after ovarian hyperstimulation.
Zamah AM; El-Sayed YY; Milki AA
Fertil Steril; 2008 Oct; 90(4):1202.e7-10. PubMed ID: 18929050
[TBL] [Abstract][Full Text] [Related]
18. [The ovarian hyperstimulation syndrome in pregnancy after IVF-ET].
Kozovski I; Markova V; Andonov M
Akush Ginekol (Sofiia); 1998; 37(2):26-7. PubMed ID: 9859531
[TBL] [Abstract][Full Text] [Related]
19. In vitro fertilization in the polycystic ovary syndrome patient: an update.
Lin K; Coutifaris C
Clin Obstet Gynecol; 2007 Mar; 50(1):268-76. PubMed ID: 17304041
[No Abstract] [Full Text] [Related]
20. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
